Democratic People's Republic of Korea vs Oman: Proportion of the target population who received
Democratic People's Republic of Korea
99.0%
in 2024
Oman
99.0%
in 2024
Democratic People's Republic of Korea rank
1st
Oman rank
1st
Proportion of the target population who received over time
- Democratic People's Republic of Korea
- Oman
How they compare
Democratic People's Republic of Korea currently reports 99.0% against 99.0% in Oman, a difference of 0.0%.
The two have swapped places 2 times across 17 shared years of data; in 2008 it was Oman ahead.
Democratic People's Republic of Korea ranks 1st and Oman ranks 1st of 193 countries.
Across the 3 decades both report, Democratic People's Republic of Korea averaged higher in 1 and Oman in 2.
Head to head by decade
| Decade | Democratic People's Republic of Korea | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.0% | 98.5% | 23.5% | Oman |
| 2010s | 85.8% | 98.9% | 13.1% | Oman |
| 2020s | 99.0% | 98.8% | 0.2% | Democratic People's Republic of Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Democratic People's Republic of Korea or Oman?
- Democratic People's Republic of Korea, at 99.0% against 99.0% in Oman as of 2024.
- What is the difference in proportion of the target population who received between Democratic People's Republic of Korea and Oman?
- 0.0%, with Democratic People's Republic of Korea ahead.
- How many years of comparable data are there for Democratic People's Republic of Korea and Oman?
- 17 years are reported by both, from 2008 to 2024.
- How do Democratic People's Republic of Korea and Oman rank globally for proportion of the target population who received?
- Democratic People's Republic of Korea ranks 1st and Oman ranks 1st of 193 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.